Demetrix is Now Offering CBG Samples

This week, we were excited to announce that Demetrix has begun to offer samples of our first product, the rare cannabinoid Cannabigerol, or CBG. You can read the full press release here.

This news follows our successful 15,000 liter demo scale production milestone last month, and is an important step forward on our path to commercialization.

CBG is an incredibly promising compound for its anti-inflammatory and antioxidant properties.  Early testing has shown it to be an effective ingredient for a range of health and wellness applications, and Demetrix is excited to be leading the way in understanding and creating safe, legal, and effective products that take advantage of CBG.

Our industry-leading fermentation process allows us to create CBG at a lower cost, faster, at higher purity, and more sustainably than agricultural methods, and we’re already exploring the more than 100 cannabinoids found in the hemp and cannabis plant. 

We’re excited to see what our innovative customers create using CBG.  If your company is interested in receiving a sample of CBG, click here.

To learn more about our mission to make the world a better place with science, visit us at www.demetrix.com, or follow us on LinkedIn or Twitter.